Chen Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chen Chen has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Renwen Wan
Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China
3 shared publications - Zhiwen Luo
Department of Orthopaedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University , Nanjing
3 shared publications - Patrick Shu-Hang Yung
The Chinese University of Hong Kong
2 shared publications - Xinting Feng
Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China
2 shared publications - Yanwei He
Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai, China
2 shared publications Buyun Chen
School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 3 April 2026
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 58, 101093
Mechanisms and precision interventions in sarcopenia and osteoarthritis comorbidity: A narrative review
- 3 April 2026
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 58, 101093
Top Cited PapersOpen AccessMechanisms and precision interventions in sarcopenia and osteoarthritis comorbidity: A narrative review
- Open Access
- 11 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (40) , 33456-33465
Tough dual-network Janus hydrogel patch for universal and reversible adhesion
In this work, a P(AAsp-AGlu)/PAADA Janus hydrogel patch is reported with excellent mechanical strength (around 410 kPa), prominent adhesion properties (over 550 J m−2) and repeatable adhesion (less than 20% decreasing after 5 adhesion cycles).
- 11 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (40) , 33456-33465
Open AccessTough dual-network Janus hydrogel patch for universal and reversible adhesion
In this work, a P(AAsp-AGlu)/PAADA Janus hydrogel patch is reported with excellent mechanical strength (around 410 kPa), prominent adhesion properties (over 550 J m−2) and repeatable adhesion (less than 20% decreasing after 5 adhesion cycles).
- Open Access
- 1 July 2025
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (4) , 1-35
Advances in artificial ligament biomaterials for anterior cruciate ligament reconstruction: material innovation, surface modification, and novel adjuvant methods
- 1 July 2025
- Published by Springer Nature in Advanced Composites and Hybrid Materials
- Vol. 8 (4) , 1-35
Open AccessAdvances in artificial ligament biomaterials for anterior cruciate ligament reconstruction: material innovation, surface modification, and novel adjuvant methods
- Open Access
- 2 January 2025
- Published by Oxford University Press (OUP) in Burns & Trauma
- Vol. 13, tkae059
Enhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes
Objective: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly impairs muscle regeneration following injuries, contributing to numerous complications and reduced quality of life. There is an urgent need for therapeutic strategies that can enhance muscle regeneration and alleviate these pathological mechanisms. In this study, we evaluate the therapeutic efficacy of W-GA nanodots, which are composed of gallic acid (GA) and tungstate (W6+), on muscle regeneration in type 2 diabetes mellitus (T2D)-induced muscle injury, with a focus on their anti-inflammatory and antioxidative effects. Methods: This study synthesized ultrasmall W-GA nanodots that were optimized for improved stability and bioactivity under physiological conditions. In vitro assessments included cell viability, apoptosis, reactive oxygen species (ROS) generation, and myotube differentiation in C2C12 myoblasts under hyperglycemic conditions. In vivo, T2D was induced in C57BL/6 mice, followed by muscle injury and treatment with W-GA. Muscle repair, fibrosis, and functional recovery were assessed through histological analysis and gait analysis using the CatWalk system. Results: The W-GA nanodots significantly enhanced muscle cell proliferation, decreased ROS, and reduced apoptosis in vitro. In vivo, compared with the control group, the W-GA-treated group exhibited notably improved muscle regeneration, decreased fibrosis, and enhanced functional recovery. The treatment notably modulated the inflammatory response and oxidative stress in diabetic muscle tissues, facilitating improved regenerative dynamics and muscle function. Conclusions: W-GA nanodots effectively counter the pathological mechanisms of diabetic myopathy by enhancing regenerative capacity and reducing oxidative stress and inflammation. This nanomedicine approach offers a promising therapeutic avenue for improving muscle health and overall quality of life in individuals suffering from T2D. However, further studies are needed to explore the clinical applications and long-term efficacy of these nanodots in preventing diabetic complications.
- 2 January 2025
- Published by Oxford University Press (OUP) in Burns & Trauma
- Vol. 13, tkae059
Open AccessEnhancing diabetic muscle repair through W-GA nanodots: a nanomedicinal approach to ameliorate myopathy in type 2 diabetes
Objective: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that significantly impairs muscle regeneration following injuries, contributing to numerous complications and reduced quality of life. There is an urgent need for therapeutic strategies that can enhance muscle regeneration and alleviate these pathological mechanisms. In this study, we evaluate the therapeutic efficacy of W-GA nanodots, which are composed of gallic acid (GA) and tungstate (W6+), on muscle regeneration in type 2 diabetes mellitus (T2D)-induced muscle injury, with a focus on their anti-inflammatory and antioxidative effects. Methods: This study synthesized ultrasmall W-GA nanodots that were optimized for improved stability and bioactivity under physiological conditions. In vitro assessments included cell viability, apoptosis, reactive oxygen species (ROS) generation, and myotube differentiation in C2C12 myoblasts under hyperglycemic conditions. In vivo, T2D was induced in C57BL/6 mice, followed by muscle injury and treatment with W-GA. Muscle repair, fibrosis, and functional recovery were assessed through histological analysis and gait analysis using the CatWalk system. Results: The W-GA nanodots significantly enhanced muscle cell proliferation, decreased ROS, and reduced apoptosis in vitro. In vivo, compared with the control group, the W-GA-treated group exhibited notably improved muscle regeneration, decreased fibrosis, and enhanced functional recovery. The treatment notably modulated the inflammatory response and oxidative stress in diabetic muscle tissues, facilitating improved regenerative dynamics and muscle function. Conclusions: W-GA nanodots effectively counter the pathological mechanisms of diabetic myopathy by enhancing regenerative capacity and reducing oxidative stress and inflammation. This nanomedicine approach offers a promising therapeutic avenue for improving muscle health and overall quality of life in individuals suffering from T2D. However, further studies are needed to explore the clinical applications and long-term efficacy of these nanodots in preventing diabetic complications.